2008 Annual Meeting Abstracts
Back to 2008 Program and Abstracts
Standardization of Laparoscopic Distal Pancreatic Resection (Lapdpr) with Regional Lymphadenectomy in Malignant Pancreatic Neoplasms (Mpn)
Laureano FernáNdez-Cruz*
Surgery, Hospital Clínic, Barcelona, Spain
Some surgeons have suggested that MPN are contraindicated to LapDPR because of concerns for the radicality of resection and oncological outcomes.Herein, described the LapDPR with and without splenectomy in patients with suspected pancreatic malignancy. The LapDPR includes radical lymph node dissection of the peripancreatic, portal, hepatic and superior mesenteric areas; the Gerota fascia and fatty tissue on the adrenal gland are also removed.The LapDPR achieved 90%. Ro resection in 15 patients with ductal adenocarcinoma and 100% in 10 patients with neuroendocrine MPN.
500 Cummings Center
+1 978-927-8330
+1 978-524-0498